ISIN | IE00028OZXY1 |
---|---|
No. de valeur | |
Bloomberg Global ID | |
Nom de fond | New Capital Healthcare Disruptors Fund GBP Unhedged Acc. |
Prestataire de fonds |
EFG - New Capital
EFG Asset Management (UK) Ltd Park House, 116 Park Street London, W1K 6AP, United Kingdom Téléphone: +44 207 173 8011 E-Mail: enquiries@newcapital.com |
Prestataire de fonds | EFG - New Capital |
Représentant en Suisse |
CACEIS (Switzerland) SA Nyon Téléphone: +41 22 360 94 00 |
Distributeur(s) |
EFG Bank AG Zürich |
Classe d'actifs | Fonds en obligations |
EFC Catégorie | |
Catégorie de parts | Accumulation |
Pays d'origine | Irlande |
Conditions d'émission de parts | Pas de commission d'émission et/ou de taxes en faveur du fonds (l'émission a lieu à la valeur d'inventaire) |
Conditions de rachat de parts | Pas de commission de rachat et/ou de taxes en faveur du fonds (le rachat a lieu à la valeur d'inventaire) |
Stratégie d'investissement *** | The investment objective of the Sub-Fund is to achieve capital appreciation through investment in a portfolio of equity securities. In order to achieve its investment objective, the Sub-Fund will invest in equities issued by US companies listed or traded on Recognised Markets in the United States such as the NASDAQ, the New York Stock Exchange, the American Stock Exchange, the Chicago Mercantile Exchange and the Chicago Board of Trade across all market capitalizations. The Sub-Fund may invest up to a maximum of 20% of the Net Asset Value in non-US companies including up to 10% of its assets in securities of emerging market issuers. |
Particularités |
Prix actuel * | 112.99 GBP | 11.11.2024 |
---|---|---|
Prix précédent * | 112.00 GBP | 08.11.2024 |
Max 52 semaines * | 112.99 GBP | 11.11.2024 |
Min 52 semaines * | 90.24 GBP | 13.11.2023 |
NAV * | 112.99 GBP | 11.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Prix minimal indicatif | ||
Actifs du fonds *** | 63'866'609 | |
Actifs de la classe *** | 232'427 | |
Trading Information SIX |
YTD Performance | +11.44% |
29.12.2023 - 11.11.2024
29.12.2023 11.11.2024 |
---|---|---|
YTD Performance (en CHF) | +17.85% |
29.12.2023 - 11.11.2024
29.12.2023 11.11.2024 |
1 mois | +4.30% |
11.10.2024 - 11.11.2024
11.10.2024 11.11.2024 |
3 mois | +5.54% |
12.08.2024 - 11.11.2024
12.08.2024 11.11.2024 |
6 mois | +8.61% |
13.05.2024 - 11.11.2024
13.05.2024 11.11.2024 |
1 an | +25.21% |
13.11.2023 - 11.11.2024
13.11.2023 11.11.2024 |
2 ans | +14.47% |
11.11.2022 - 11.11.2024
11.11.2022 11.11.2024 |
3 ans | -5.74% |
11.11.2021 - 11.11.2024
11.11.2021 11.11.2024 |
5 ans | +0.06% |
26.07.2021 - 11.11.2024
26.07.2021 11.11.2024 |
Quota de participation de capital en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Part de la fortune du fonds en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quota d'immobilier en % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
argenx SE ADR | 5.68% | |
---|---|---|
Intuitive Surgical Inc | 5.22% | |
Natera Inc | 5.11% | |
Veracyte Inc | 4.78% | |
Veeva Systems Inc Class A | 4.28% | |
Ultragenyx Pharmaceutical Inc | 4.24% | |
Exact Sciences Corp | 4.22% | |
Zoetis Inc Class A | 3.97% | |
Stryker Corp | 3.94% | |
IQVIA Holdings Inc | 3.72% | |
Dernière mise à jour des données | 31.10.2024 |
TER | 1.0609% |
---|---|
Date TER | 30.06.2021 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.75% |
Ongoing Charges *** | 0.99% |
SRRI ***
|
|
Date SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |